Arca
Skip to content
Tools
Tools

DNA

Nucleic acid in Mycobacterium leprae that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Clofazimine

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        ClofazimineApprovedNovartis PharmaceuticalsSmall moleculeInhibitorDNA inhibitor16

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)ClofaziminePhase 2Not yet recruitingFondation Raoul FollereauNov 5, 2026
        Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialClofaziminePhase 2Not yet recruitingThe University of QueenslandMar 20, 2026
        Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionClofaziminePhase 1Enrolling by invitationVancouver Coastal HealthNov 14, 2025
        6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei ProvinceClofazimineNot applicableNot yet recruitingWuhan Pulmonary HospitalSep 30, 2025
        A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsClofaziminePhase 2RecruitingWestVac Biopharma Co., Ltd.Sep 12, 2025
        A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant TuberculosisClofazimineNot applicableNot yet recruitingWuhan Pulmonary HospitalAug 17, 2025
        Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsClofazimineNot applicableRecruitingSouth Valley UniversityFeb 11, 2025
        Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese CohortClofaziminePhase 3Active, not recruitingHuashan HospitalOct 21, 2024

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2366041, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.